Login to Your Account



Acceleron Pharma Prices Upbeat IPO

By Peter Winter
BioWorld Insight Edtor

Friday, September 20, 2013
The sky is getting crowded as biotech companies on the initial public offering (IPO) runway continue to take off with increasing regularity. The latest to get airborne is Cambridge, Mass.-based Acceleron Pharma Inc., which priced its IPO Thursday.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription